Table 4 Univariate and multivariate analysis to predict all-cause mortality after HTx.

From: Impact of preoperative renal replacement therapy on the clinical outcome of heart transplant patients

 

Univariate

Multivariate

HR

95% CI

p

HR

95% CI

p

Age, year

1.022

0.999–1.039

0.075

1.018

0.988–1.029

0.295

Male

1.193

0.703–2.023

0.514

   

DM

1.843

1.136–2.979

0.013

1.749

0.942 – 2.670

0.083

Insulin-dependent DM

1.742

0.723–4.164

0.217

   

Preoperative mechanical ventilation

2.874

1.782–4.630

 < 0.001

1.394

0.674–2.879

0.893

Preoperative mechanical cardiac support

2.742

1.705–4.410

 < 0.001

1.510

0.743–3.048

0.437

Preoperative RRT

2.743

2.302–6.084

 < 0.001

1.306

0.723–2.359

0.515

Preoperative eGFR, ml/min/1.73 m2

0.993

0.992–1.005

0.588

   

Preoperative creatinine, mg/dL

1.044

0.882–1.297

0.753

   

Postoperative RRT

6.413

3.949–10.417

 < 0.001

4.396

2.469–7.828

 < 0.001

ESRD after HTx

5.142

2.464–10.725

 < 0.001

1.142

0.708–2.814

0.327

Primary graft failure

2.955

1.373–6.316

0.006

2.434

1.407–4.213

0.001

  1. DM diabetes mellitus, RRT renal replacement therapy, eGFR estimated glomerular filtration rate, HTx heart transplantation, ESRD end-stage renal disease.
Back to article page